Beyond Air
NASDAQ: XAIRGarden City, US · Founded 2015 · Delaware corporation
Biotech
Founders & leadership
MA
Michael A. GaulChief Operating Officer
AA
Amir AvnielChief Business Officer
DQ
Douglas Quinton LarsonChief Financial Officer
SA
Steven A. LisiChairman and CEO
JL
Jason LaneExecutive Officer, Director
RC
Robert CareyDirector
RB
Ron BentsurDirector
YL
Yoori LeeDirector
EL
Erick LuceraDirector
WP
William P. ForbesDirector
Reported raises · per SEC filings
Form D private placements▶$20.6MraisedOct 2024 · 15 investors · BiotechnologyRule 506(b)
▶$20.6MraisedOct 2024 · 15 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Steven A. LisiExecutive Officer, Director
- Yoori LeeDirector
- Robert CareyDirector
- Michael A. GaulExecutive Officer
- Erick LuceraDirector
- Douglas Quinton LarsonExecutive Officer
- Ron BentsurDirector
- William P. ForbesDirector
- Offering amount
- $20.6M
- Amount sold
- $20.6M
- Sales commissions
- $1.4M
- Placement agents
- Laidlaw & Company (UK) LTD, JONESTRADING INSTITUTIONAL SERVICES LLC, Brookline Capital Markets, a division of Arcadia Securities, LLC, BTIG, LLC
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$128KraisedJul 2024 · 2 investors · BiotechnologyRule 506(b)
▶$128KraisedJul 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert CareyDirector
- Michael A. GaulExecutive Officer
- Ron BentsurDirector
- Yoori LeeDirector
- Erick LuceraDirector
- Amir AvnielDirector, Executive Officer
- William P. ForbesDirector
- Douglas Quinton LarsonExecutive Officer
- Steven A. LisiDirector, Executive Officer
- Offering amount
- $128K
- Amount sold
- $128K
- First sale
- Jun 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedJun 2023 · 2 investors · BiotechnologyRule 506(b)
▶$1.4MraisedJun 2023 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Erick LuceraDirector
- Ron BentsurDirector
- Jeff Lynn MyersExecutive Officer
- Robert CareyDirector
- William P ForbesDirector
- Yoori LeeDirector
- Michael A. GaulExecutive Officer
- Steven A. LisiExecutive Officer, Director
- Douglas Quinton LarsonExecutive Officer
- Amir AvnielExecutive Officer, Director
- Offering amount
- $1.4M
- Amount sold
- $1.4M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$8MraisedJun 2019 · 47 investors · BiotechnologyRule 506(b)
▶$8MraisedJun 2019 · 47 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lee YooriDirector
- Forbes WilliamDirector
- Bentsur RonDirector
- Carey RobertDirector
- Avniel AmirExecutive Officer, Director
- Beck DouglasExecutive Officer
- Steven LisiExecutive Officer, Director
- Lucera ErickDirector
- Offering amount
- $8M
- Amount sold
- $8M
- First sale
- Jun 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$9.8MraisedMar 2018 · 58 investors · PharmaceuticalsRule 506(b)
▶$9.8MraisedMar 2018 · 58 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Hai AvivExecutive Officer
- David GrossmanDirector
- Amir AvnielDirector, Executive Officer
- Erick J. LuceraDirector
- Yoori LeeDirector
- Steven A. LisiExecutive Officer, Director
- Ari RavedDirector
- Ron BentsurDirector
- Offering amount
- $9.8M
- Amount sold
- $9.8M
- Sales commissions
- $687.4K
- Placement agents
- Laidlaw & Company (UK) Ltd., Brookline Capital Markets
- First sale
- Feb 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$663KraisedApr 2017 · 22 investors · PharmaceuticalsRule 506(b)
▶$663KraisedApr 2017 · 22 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David GrossmanDirector
- Amir AvnielExecutive Officer, Director
- Ari RavedDirector
- Haim AvivExecutive Officer
- Jerome ZeldisDirector
- Steven LisiDirector
- Ron BentsurDirector
- Yossef Av-GayDirector
- Offering amount
- $10M
- Amount sold
- $663K
- Sales commissions
- $79.6K
- Placement agents
- Laidlaw & Company (UK) Ltd.
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$37MraisedJan 2017 · 58 investors · PharmaceuticalsRule 506(b)
▶$37MraisedJan 2017 · 58 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Steven A. LisiDirector
- Ron BentsurDirector
- Racheli VizmanExecutive Officer
- Yossef Av-GayDirector
- Amir AvnielExecutive Officer, Director
- David GrossmanDirector
- Jerome B. ZeldisDirector
- Ari RavedDirector
- Offering amount
- $37M
- Amount sold
- $37M
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$10KofferedMay 2015 · Other TechnologyRule 506(b)
▶$10KofferedMay 2015 · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Jason LaneExecutive Officer, Director
- Offering amount
- $10K
- Minimum investment
- $100
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.